Stay updated with breaking news from Waning Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent study assessed the waning efficacy of the BioNTech/Pfizer BNT162b2 mRNA vaccine against the SARS-CoV-2 Omicron VOC.
In a new study, researchers determined the vaccine effectiveness against SARS-CoV-2 in older individuals.
Researchers have conducted a retrospective matched case-control study to determine the protection period conferred by the BNT162b2 vaccine on adolescents aged 12 to 16.